REFERENCES
- Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingan SS. Lung cancer in elderly patients: an analysis of the Surveillance, Epidemiology, and End Results Database. J Clin Oncol 2007 25:5570–5577.
- Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, Aapro MS, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margogno B, Ihinose Y, Nishikawi Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. EORTC cancer in the elderly task force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003 39:2264–2272.
- The Elderly Lung Cancer Vinorelbine Italian Study Group. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 1999 91:66–72.
- Wheatley-Price P, Ding K, Seymour L, Clark GM, Shepherd FA Erlotinib for advanced non-small cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR21. J Clin Oncol 2008 26:2350–2357.
- Jatoi A, Stella PJ, Hillman S, Maillirad JA, Vanone S, Perez EA, Cannon MW, Geyer S, Wiesenfeld M, Jett JR. Weekly carboplatin and paclitaxel in elderly non-small cell lung cancer patients: a phase II North Central Cancer Treatment Group study. Am J Clin Oncol 2003 26:441–447.
- Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ihinose Y, Nishikawi Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009 361:947–957.